MD Integrations

M & D Integrations, Inc. DBA MD Integrations is a US-based company specializing in advanced integration solutions that enhance operational efficiency for businesses across various sectors, including healthcare and finance. Founded in 2021 by founder and CEO Marc Serota, and headquartered in New York, US, M & D Integrations, Inc. DBA MD Integrations focuses on providing seamless integration solutions for businesses.

In October 2025, MD Integrations raised USD 77 million in venture funding from investors Updata Partners and Denali Growth Partners. M D Integrations specializes in providing advanced integration solutions designed to streamline operations for businesses across various sectors. Their core offerings include a suite of software applications that enable seamless connectivity between disparate systems, enhancing data sharing and operational efficiency. Their products cater to a diverse clientele, including healthcare providers, financial institutions, and retail organizations.

The end-users of M D Integrations' solutions are typically IT professionals and business analysts who leverage these tools to facilitate data-driven decision-making processes. Solutions are available in multiple geographical markets, including North America, Europe, and Asia, addressing the unique integration challenges faced by businesses in these regions. M D Integrations generates revenue primarily through a subscription-based model, allowing clients to access their software solutions on a recurring basis. Transactions typically occur between the firm and its clients, which include both large enterprises and small to medium-sized businesses.

Clients engage in annual subscriptions or multi-year contracts, depending on their needs and the scale of implementation. Specific pricing plans are structured around the complexity and scope of the services offered, fostering long-term partnerships as clients invest in ongoing support and updates to ensure their systems remain efficient and effective. The company will use the October 2025 funding to expand its partner base, grow its physician network, and enhance pharmacy, diagnostics, and API platform integrations.